Profile | GDS4284 / 35201_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1459.22 | 79 |
GSM687648 | Patient 402 control | 1807.39 | 82 |
GSM687653 | Patient 403 control | 1413.61 | 79 |
GSM687658 | Patient 404 control | 1754.9 | 82 |
GSM687663 | Patient 411 control | 2053.18 | 84 |
GSM687668 | Patient 422 control | 1646.52 | 81 |
GSM687673 | Patient 424 control | 2150.96 | 85 |
GSM687678 | Patient 425 control | 1177.21 | 76 |
GSM687683 | Patient 427 control | 1613.49 | 81 |
GSM687688 | Patient 428 control | 1681.21 | 81 |
GSM687695 | Patient 441 control | 2895.07 | 89 |
GSM687699 | Patient 443 control | 2077.22 | 85 |
GSM687704 | Patient 444 control | 1988.9 | 84 |
GSM687707 | Patient 448 control | 1817.66 | 83 |
GSM687712 | Patient 449 control | 1927.63 | 84 |
GSM687719 | Patient 450 control | 1674.83 | 82 |
GSM687724 | Patient 451 control | 1784.01 | 83 |
GSM687728 | Patient 452 control | 2149.44 | 85 |
GSM687646 | Patient 401 treated 24h | 1546.49 | 80 |
GSM687649 | Patient 402 treated 24h | 1399.74 | 79 |
GSM687665 | Patient 411 treated 24h | 2007.87 | 84 |
GSM687651 | Patient 402 treated 4 weeks | 2438.46 | 86 |
GSM687667 | Patient 411 treated 4 weeks | 1460.76 | 79 |
GSM687670 | Patient 422 treated 24h | 1576.12 | 80 |
GSM687671 | Patient 422 treated 4 weeks | 1532.03 | 80 |
GSM687654 | Patient 403 treated 24h | 1613.01 | 81 |
GSM687675 | Patient 424 treated 24h | 2342.88 | 86 |
GSM687685 | Patient 427 treated 24h | 1700.23 | 82 |
GSM687656 | Patient 403 treated 4 weeks | 1475.14 | 80 |
GSM687677 | Patient 424 treated 4 weeks | 2138.49 | 85 |
GSM687687 | Patient 427 treated 4 weeks | 1788.72 | 82 |
GSM687692 | Patient 428 treated 4h | 1317.97 | 78 |
GSM687716 | Patient 449 treated 4h | 1393.33 | 79 |
GSM687722 | Patient 450 treated 4h | 1927.46 | 84 |
GSM687680 | Patient 425 treated 24h | 1288.35 | 78 |
GSM687690 | Patient 428 treated 24h | 1448.58 | 80 |
GSM687700 | Patient 443 treated 24h | 2653.97 | 88 |
GSM687705 | Patient 444 treated 24h | 1626.28 | 81 |
GSM687714 | Patient 449 treated 24h | 1402.29 | 79 |
GSM687721 | Patient 450 treated 24h | 2082.1 | 85 |
GSM687682 | Patient 425 treated 4 weeks | 1392.53 | 79 |
GSM687694 | Patient 428 treated 4 weeks | 1447.9 | 79 |
GSM687702 | Patient 443 treated 4 weeks | 1880.33 | 83 |
GSM687718 | Patient 449 treated 4 weeks | 1644.82 | 82 |
GSM687723 | Patient 450 treated 4 weeks | 1500.28 | 80 |
GSM687661 | Patient 404 treated 4h | 1986 | 84 |
GSM687710 | Patient 448 treated 4h | 1673.54 | 82 |
GSM687726 | Patient 451 treated 4h | 1997.87 | 84 |
GSM687730 | Patient 452 treated 4h | 6089.08 | 95 |
GSM687660 | Patient 404 treated 24h | 2286.59 | 87 |
GSM687697 | Patient 441 treated 24h | 2593.62 | 88 |
GSM687709 | Patient 448 treated 24h | 2179.92 | 85 |
GSM687725 | Patient 451 treated 24h | 2290.67 | 86 |
GSM687729 | Patient 452 treated 24h | 2299.32 | 87 |
GSM687727 | Patient 451 treated 4 weeks | 1554.05 | 81 |
GSM687731 | Patient 452 treated 4 weeks | 2135.76 | 85 |